Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Malcolm J Moore

Multicenter Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET).

Journal of Clinical Oncology

Cancer Research

English

Cost-Effectiveness of FOLFIRINOX for First-Line Treatment of Metastatic Pancreatic Cancer.

Journal of Clinical Oncology

Cancer Research

English

Related publications

From Parenchymal Preservation to Multiorgan Resection in Pancreatic Neuroendocrine Tumors (pNET), a Tailored Resection Based in Tumor Biology

Gastroenterology

English

Could Radical Antegrade Modular Pancreatosplenectomy (RAMPS) Be Indicated in Pancreatic Neuroendocrine Tumors (pNET)?

Gastroenterology

English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer

English

Gastric Gastrointestinal Stromal Tumor and Neuroendocrine Pancreatic Tumor: Always Neurofibromatosis?

Endoscopic Ultrasound

Nuclear Medicine

Gastroenterology

English

A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas

British Journal of Cancer

Cancer Research

English

Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology

English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer

Cancer Research

English

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)

Cancer Research

English

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Investigational New Drugs

English